Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1956 1
1959 2
1960 1
1961 2
1962 5
1963 3
1964 2
1965 2
1966 2
1967 1
1968 1
1969 2
1970 3
1971 1
1972 1
1973 1
1974 5
1975 6
1976 1
1977 15
1978 7
1979 6
1980 6
1981 5
1982 9
1983 10
1984 12
1985 14
1986 15
1987 20
1988 26
1989 18
1990 22
1991 32
1992 26
1993 37
1994 27
1995 35
1996 40
1997 37
1998 40
1999 47
2000 44
2001 44
2002 54
2003 49
2004 59
2005 70
2006 56
2007 64
2008 51
2009 79
2010 115
2011 120
2012 124
2013 151
2014 148
2015 150
2016 157
2017 167
2018 155
2019 143
2020 146
2021 196
2022 182
2023 177
2024 161
2025 152
2026 86

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,332 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean shin c[au] (3,099 results)?
Pembrolizumab in HER2-Positive Gastric Cancer.
Janjigian YY, Kawazoe A, Bai Y, Xu J, Lonardi S, Metges JP, Yañez P, Wyrwicz LS, Shen L, Ostapenko Y, Bilici M, Chung HC, Shitara K, Qin S, Van Cutsem E, Tabernero J, Luo S, Mahave M, Tang Y, Lowery M, Monteiro MMF, Xu L, Shih CS, Sharan KP, Bhagia P, Rha SY. Janjigian YY, et al. Among authors: shih cs. N Engl J Med. 2024 Oct 10;391(14):1360-1362. doi: 10.1056/NEJMc2408121. Epub 2024 Sep 14. N Engl J Med. 2024. PMID: 39282917 Free PMC article. No abstract available.
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.
Janjigian YY, Kawazoe A, Bai Y, Xu J, Lonardi S, Metges JP, Yanez P, Wyrwicz LS, Shen L, Ostapenko Y, Bilici M, Chung HC, Shitara K, Qin SK, Van Cutsem E, Tabernero J, Li K, Shih CS, Bhagia P, Rha SY; KEYNOTE-811 Investigators. Janjigian YY, et al. Among authors: shih cs. Lancet. 2023 Dec 9;402(10418):2197-2208. doi: 10.1016/S0140-6736(23)02033-0. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871604 Clinical Trial.
Architecture of the neutrophil compartment.
Cerezo-Wallis D, Rubio-Ponce A, Richter M, Pitino E, Kwok I, Marteletto G, Guanolema-Coba AC, Shih C, Huang RK, Moraga A, Bravo NB, Doré S, Callejas S, Aragonés DG, Jiménez-Carretero D, Martin D, Ovadia S, Vicanolo T, Crainiciuc G, Sicilia J, Deng T, Martin A, Zhang J, Cuartero MI, Giraldo DM, Garcia-Culebras A, Aroca-Crevillen A, Martín-Salamanca S, Torroja C, Ruiz M, Ruano I, Ng MSF, Hou J, Wang Y, Zhang M, Pu J, Herruzo A, van Oordt DC, Chang S, Downie AE, Chen F, Graham AL, Gause WC, Fiset PO, Spicer JD, Heyn H, Zuriaga MA, Bernal JA, Udalova IA, Moro MA, de Bock K, Dopazo A, Fuster JJ, Sánchez-Cabo F, Nieto JC, Calvo GF, Skokowa J, Soehnlein O, Quail DF, Walsh LA, Ng LG, Hidalgo A, Ballesteros I. Cerezo-Wallis D, et al. Among authors: shih c. Nature. 2026 Jan;649(8098):1003-1012. doi: 10.1038/s41586-025-09807-0. Epub 2025 Dec 3. Nature. 2026. PMID: 41339555 Free PMC article.
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K, Rha SY, Wyrwicz LS, Oshima T, Karaseva N, Osipov M, Yasui H, Yabusaki H, Afanasyev S, Park YK, Al-Batran SE, Yoshikawa T, Yanez P, Dib Bartolomeo M, Lonardi S, Tabernero J, Van Cutsem E, Janjigian YY, Oh DY, Xu J, Fang X, Shih CS, Bhagia P, Bang YJ; KEYNOTE-585 investigators. Shitara K, et al. Among authors: shih cs. Lancet Oncol. 2024 Feb;25(2):212-224. doi: 10.1016/S1470-2045(23)00541-7. Epub 2023 Dec 19. Lancet Oncol. 2024. PMID: 38134948 Clinical Trial.
What Will Deliver the Best Bang-For-Your-Treatment-Buck? Treatment Effects of Physical Therapy Approaches to Managing Chronic Ankle Instability: A Network Meta-Analysis of Randomized Controlled Trials.
Yang YS, Lai PC, Liu ZW, Fang CJ, Tu YK, Chang CH, Huang MT, Wu PT, Su WR, Hong CK, Kuan FC, Hsu KL, Chang CW, Lin CJ, Shih CA. Yang YS, et al. Among authors: shih ca. J Orthop Sports Phys Ther. 2025 Jan;55(1):26-44. doi: 10.2519/jospt.2024.12601. J Orthop Sports Phys Ther. 2025. PMID: 39741454 Review.
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Yang HC, Kwok PY, Li LH, Liu YM, Jong YJ, Lee KY, Wang DW, Tsai MF, Yang JH, Chen CH, Yeh EC, Wei CY, Fann CS, Huang YT, Chen CW, Lee YJ, Chu SK, Ho CH, Yang CS, Lee YL, Chen HH, Hou MC, Chiou JF, Yang SF, Wang CH, Huang CY, Chiu KM, Chen M, Chiang FT, Lee SL, Chen SS, Yao WJ, Chien CC, Lin SY, Chang FP, Ho HL, Yeh YC, Tseng WC, Lin MH, Chang HT, Tseng LM, Liang WY, Chen PC, Hang JF, Lin SC, Chan YJ, Kuo YJ, Wang LC, Pan CC, Hsieh YC, Chen YM, Hsiao TH, Lin CH, Chen YJ, Chen IC, Mao CL, Chang SJ, Chang YL, Liao YJ, Lai CH, Lee WJ, Tung H, Yen TT, Yen HC, Shih CM, Chou TY, Liou TH, Chiang CY, Cherng YG, Chen CH, Chiu CH, Tseng SH, Lin EP, Chen YJ, Chuang HP, Chen TC, Huang WT, Sin J, Liu IL, Chen YC, Chao KK, Wu YM, Yu PP, Chang LP, Yen KY, Chang LC, Sheen YJ, Chen YT, Kan K, Tsai HL, Wang YK, Hou MF, Yang YH, Kuo CH, Wu WJ, Huang JF, Chong IW, Tsai JR, Lin CY, Yu MC, Lee TH, Tsai MH, Ou YC, Chen PY, Hu TH, Shyu YC, Cheng CK, Fang YJ, Hsieh SC, Chen CH, Chen CC, Li KJ, Lin CH, Chiu HY, Wu CC, Chen CY, Chu SJ, Liu FC, Yang FC, Chang HA, Chen WL, Yang SS, Sung YF, Wang TF, Lin SZ, Wu YW, Wu CS, Jiang JY, Ma GC, Chang TY, Hwang JJ, Kao KJ, Hung CF, Chiu TF, Chen PY, Tsui K, Wu … See abstract for full author list ➔ Yang HC, et al. Among authors: shih cm. Nature. 2025 Dec;648(8092):117-127. doi: 10.1038/s41586-025-09680-x. Epub 2025 Oct 15. Nature. 2025. PMID: 41092961 Free PMC article.
Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized Trial.
Hsu PI, Chen CL, Shih CA, Chen KY, Tai WC, Chuah SK, Lee CL, Tsay FW, Yang JC, Lei WY, Kuo CH, Shie CB, Lee HC, Yamaoka Y, Graham DY, Wu DC; Taiwan Acid-related Disease and Microbiota (TARD-M) Consortium. Hsu PI, et al. Among authors: shih ca. Am J Gastroenterol. 2025 Jun 16. doi: 10.14309/ajg.0000000000003607. Online ahead of print. Am J Gastroenterol. 2025. PMID: 40560185
3,332 results